Literature DB >> 22351776

Enzyme kinetics and interaction studies for human JNK1β1 and substrates activating transcription factor 2 (ATF2) and c-Jun N-terminal kinase (c-Jun).

Mariana Figuera-Losada1, Philip V LoGrasso.   

Abstract

c-Jun N-terminal kinase (JNK) is a stress signal transducer linked to cell death, and survival. JNK1 has been implicated in obesity, glucose intolerance, and insulin resistance. In this study we report the kinetic mechanism for JNK1β1 with transcription factors ATF2 and c-Jun along with interaction kinetics for these substrates. JNK1β1 followed a random sequential mechanism forming a ternary complex between JNK-substrate-ATP. K(m) for ATF2 and c-Jun was 1.1 and 2.8 μM, respectively. Inhibition studies using adenosine 5'-(β,γ-methylenetriphosphate) and a peptide derived from JNK interacting protein 1 (JIP1) supported the proposed kinetic mechanism. Biolayer interferometry studies showed that unphosphorylated JNK1β1 bound to ATF2 with similar affinity as it did to c-Jun (K(D) = 2.60 ± 0.34 versus 1.00 ± 0.35 μM, respectively). The presence of ATP increased the affinity of unphosphorylated JNK1β1 for ATF2 and c-Jun, to 0.80 ± 0.04 versus 0.65 ± 0.07 μM, respectively. Phosphorylation of JNK1β1 decreased the affinity of the kinase for ATF2 to 11.0 ± 1.1 μM and for c-Jun to 17.0 ± 7.5 μM in the absence of ATP. The presence of ATP caused a shift in the K(D) of the active kinase for ATF2 to 1.70 ± 0.25 μM and for c-Jun of 3.50 ± 0.95 μM. These results are the first kinetic and biochemical characterization of JNK1β1 and uncover some of the differences in the enzymatic activity of JNK1β1 compared with other variants and suggest that ATP binding or JNK phosphorylation could induce changes in the interactions with substrates, activators, and regulatory proteins.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22351776      PMCID: PMC3339953          DOI: 10.1074/jbc.M111.323766

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

Review 1.  Signal transduction by the JNK group of MAP kinases.

Authors:  R J Davis
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

2.  The gene MAPK8IP1, encoding islet-brain-1, is a candidate for type 2 diabetes.

Authors:  G Waeber; J Delplanque; C Bonny; V Mooser; M Steinmann; C Widmann; A Maillard; J Miklossy; C Dina; E H Hani; N Vionnet; P Nicod; P Boutin; P Froguel
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

3.  c-Jun N-terminal kinase (JNK) and JNK interacting protein response in rat brain after transient middle cerebral artery occlusion.

Authors:  T Hayashi; K Sakai; C Sasaki; W R Zhang; H Warita; K Abe
Journal:  Neurosci Lett       Date:  2000-04-28       Impact factor: 3.046

4.  JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins.

Authors:  Lufen Chang; Ying Jones; Mark H Ellisman; Lawrence S B Goldstein; Michael Karin
Journal:  Dev Cell       Date:  2003-04       Impact factor: 12.270

5.  JNK3 contributes to c-Jun activation and apoptosis but not oxidative stress in nerve growth factor-deprived sympathetic neurons.

Authors:  S R Bruckner; S P Tammariello; C Y Kuan; R A Flavell; P Rakic; S Estus
Journal:  J Neurochem       Date:  2001-07       Impact factor: 5.372

6.  Isoforms of Jun kinase are differentially expressed and activated in human monocyte/macrophage (THP-1) cells.

Authors:  S C Dreskin; G W Thomas; S N Dale; L E Heasley
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

7.  Identification of the critical features of a small peptide inhibitor of JNK activity.

Authors:  Renae K Barr; Tulene S Kendrick; Marie A Bogoyevitch
Journal:  J Biol Chem       Date:  2002-01-14       Impact factor: 5.157

8.  Design and synthesis of a novel, orally active, brain penetrant, tri-substituted thiophene based JNK inhibitor.

Authors:  Simeon Bowers; Anh P Truong; R Jeffrey Neitz; Martin Neitzel; Gary D Probst; Roy K Hom; Brian Peterson; Robert A Galemmo; Andrei W Konradi; Hing L Sham; Gergley Tóth; Hu Pan; Nanhua Yao; Dean R Artis; Elizabeth F Brigham; Kevin P Quinn; John-Michael Sauer; Kyle Powell; Lany Ruslim; Zhao Ren; Frédérique Bard; Ted A Yednock; Irene Griswold-Prenner
Journal:  Bioorg Med Chem Lett       Date:  2011-01-20       Impact factor: 2.823

9.  Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand.

Authors:  Y Morishima; Y Gotoh; J Zieg; T Barrett; H Takano; R Flavell; R J Davis; Y Shirasaki; M E Greenberg
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

10.  A central role for JNK in obesity and insulin resistance.

Authors:  Jiro Hirosumi; Gürol Tuncman; Lufen Chang; Cem Z Görgün; K Teoman Uysal; Kazuhisa Maeda; Michael Karin; Gökhan S Hotamisligil
Journal:  Nature       Date:  2002-11-21       Impact factor: 49.962

View more
  9 in total

1.  Maternal chromium restriction modulates miRNA profiles related to lipid metabolism disorder in mice offspring.

Authors:  Qian Zhang; Xinhua Xiao; Jia Zheng; Ming Li; Miao Yu; Fan Ping; Zhixin Wang; Cuijuan Qi; Tong Wang; Xiaojing Wang
Journal:  Exp Biol Med (Maywood)       Date:  2017-07-01

2.  Structural mechanisms of allostery and autoinhibition in JNK family kinases.

Authors:  John D Laughlin; Jerome C Nwachukwu; Mariana Figuera-Losada; Lisa Cherry; Kendall W Nettles; Philip V LoGrasso
Journal:  Structure       Date:  2012-11-08       Impact factor: 5.006

Review 3.  JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships.

Authors:  András Zeke; Mariya Misheva; Attila Reményi; Marie A Bogoyevitch
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-27       Impact factor: 11.056

4.  SRp55 Regulates a Splicing Network That Controls Human Pancreatic β-Cell Function and Survival.

Authors:  Jonàs Juan-Mateu; Maria Inês Alvelos; Jean-Valéry Turatsinze; Olatz Villate; Esther Lizarraga-Mollinedo; Fabio Arturo Grieco; Laura Marroquí; Marco Bugliani; Piero Marchetti; Décio L Eizirik
Journal:  Diabetes       Date:  2017-12-15       Impact factor: 9.461

5.  A small molecule bidentate-binding dual inhibitor probe of the LRRK2 and JNK kinases.

Authors:  Yangbo Feng; Jeremy W Chambers; Sarah Iqbal; Marcel Koenig; HaJeung Park; Lisa Cherry; Pamela Hernandez; Mariana Figuera-Losada; Philip V LoGrasso
Journal:  ACS Chem Biol       Date:  2013-06-10       Impact factor: 5.100

Review 6.  Phosphorylation Dynamics of JNK Signaling: Effects of Dual-Specificity Phosphatases (DUSPs) on the JNK Pathway.

Authors:  Jain Ha; Eunjeong Kang; Jihye Seo; Sayeon Cho
Journal:  Int J Mol Sci       Date:  2019-12-06       Impact factor: 5.923

7.  High throughput solution-based measurement of antibody-antigen affinity and epitope binning.

Authors:  Patricia Estep; Felicia Reid; Claire Nauman; Yuqi Liu; Tingwan Sun; Joanne Sun; Yingda Xu
Journal:  MAbs       Date:  2013 Mar-Apr       Impact factor: 5.857

8.  Effects of Maternal Chromium Restriction on the Long-Term Programming in MAPK Signaling Pathway of Lipid Metabolism in Mice.

Authors:  Qian Zhang; Xiaofang Sun; Xinhua Xiao; Jia Zheng; Ming Li; Miao Yu; Fan Ping; Zhixin Wang; Cuijuan Qi; Tong Wang; Xiaojing Wang
Journal:  Nutrients       Date:  2016-08-10       Impact factor: 5.717

9.  Conformational Design and Characterisation of a Truncated Diamine Oxidase from Arthrobacter globiformis.

Authors:  Nur Nadia Razali; Nur Hafizah Hashim; Adam Thean Chor Leow; Abu Bakar Salleh
Journal:  High Throughput       Date:  2018-08-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.